These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Review article: the investigation and management of gastric neuroendocrine tumours. Basuroy R, Srirajaskanthan R, Prachalias A, Quaglia A, Ramage JK. Aliment Pharmacol Ther; 2014 May; 39(10):1071-84. PubMed ID: 24628514 [Abstract] [Full Text] [Related]
23. Effects of tumor types on treatment strategy formulation and prognostic evaluation of gastric neuroendocrine tumors. Jiao X, Wang Z, Peng X, Zhang L, Zhou L. Future Oncol; 2020 Oct; 16(28):2197-2207. PubMed ID: 32687408 [Abstract] [Full Text] [Related]
24. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Scherübl H, Cadiot G, Jensen RT, Rösch T, Stölzel U, Klöppel G. Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078 [Abstract] [Full Text] [Related]
25. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Bordi C, Falchetti A, Azzoni C, D'Adda T, Canavese G, Guariglia A, Santini D, Tomassetti P, Brandi ML. Am J Surg Pathol; 1997 Sep; 21(9):1075-82. PubMed ID: 9298884 [Abstract] [Full Text] [Related]
27. Gastroduodenal neuroendocrine neoplasms, including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Lipiński M, Rydzewska G, Foltyn W, Andrysiak-Mamos E, Bałdys-Waligórska A, Bednarczuk T, Blicharz-Dorniak J, Bolanowski M, Boratyn-Nowicka A, Borowska M, Cichocki A, Ćwikła JB, Falconi M, Handkiewicz-Junak D, Hubalewska-Dydejczyk A, Jarząb B, Junik R, Kajdaniuk D, Kamiński G, Kolasińska-Ćwikła A, Kowalska A, Król R, Królicki L, Kunikowska J, Kuśnierz K, Lampe P, Lange D, Lewczuk-Myślicka A, Lewiński A, Londzin-Olesik M, Marek B, Nasierowska-Guttmejer A, Nowakowska-Duława E, Pilch-Kowalczyk J, Poczkaj K, Rosiek V, Ruchała M, Siemińska L, Sowa-Staszczak A, Starzyńska T, Steinhof-Radwańska K, Strzelczyk J, Sworczak K, Syrenicz A, Szawłowski A, Szczepkowski M, Wachuła E, Zajęcki W, Zemczak A, Zgliczyński W, Kos-Kudła B. Endokrynol Pol; 2017 Mar 12; 68(2):138-153. PubMed ID: 28540972 [Abstract] [Full Text] [Related]
28. The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors. Esposito G, Dell'Unto E, Ligato I, Marasco M, Panzuto F. Expert Rev Gastroenterol Hepatol; 2023 Mar 12; 17(8):785-793. PubMed ID: 37497604 [Abstract] [Full Text] [Related]
29. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up. Vanoli A, La Rosa S, Miceli E, Klersy C, Maragliano R, Capuano F, Persichella A, Martino M, Inzani F, Luinetti O, Di Sabatino A, Sessa F, Paulli M, Corazza GR, Rindi G, Bordi C, Capella C, Solcia E. Neuroendocrinology; 2018 Mar 12; 107(2):114-126. PubMed ID: 29895024 [Abstract] [Full Text] [Related]
30. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors. Jung HJ, Hong SJ, Han JP, Kim HS, Jeong GA, Cho GS, Kim HK, Ko BM, Lee MS. J Dig Dis; 2015 Oct 12; 16(10):595-600. PubMed ID: 26315879 [Abstract] [Full Text] [Related]
31. Benign glandular downgrowth in gastric neuroendocrine neoplasms: a potential mimic of composite tumour. Ramineni M, Taggart MW, Rashid A, Abraham SC. Histopathology; 2014 Dec 12; 65(6):897-907. PubMed ID: 25041266 [Abstract] [Full Text] [Related]
32. Clinicopathologic aspects of gastric neuroendocrine tumors. Rindi G. Am J Surg Pathol; 1995 Dec 12; 19 Suppl 1():S20-9. PubMed ID: 7762736 [Abstract] [Full Text] [Related]
33. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis. Pieterman CR, Conemans EB, Dreijerink KM, de Laat JM, Timmers HT, Vriens MR, Valk GD. Endocr Relat Cancer; 2014 Jun 12; 21(3):R121-42. PubMed ID: 24389729 [Abstract] [Full Text] [Related]
34. Gastric neuroendocrine neoplasms. Lamberti G, Panzuto F, Pavel M, O'Toole D, Ambrosini V, Falconi M, Garcia-Carbonero R, Riechelmann RP, Rindi G, Campana D. Nat Rev Dis Primers; 2024 Apr 11; 10(1):25. PubMed ID: 38605021 [Abstract] [Full Text] [Related]
36. [Current opinions on pathogenesis, diagnostic procedures and management of gastric neuroendocrine tumors]. Gilis-Januszewska A, Baczyńska E, Szybiński P, Sowa-Staszczak A, Trofimiuk M, Pach D, Tomaszewska R, Hubalewska-Dydejczyk A. Przegl Lek; 2009 Apr 11; 66(12):1052-61. PubMed ID: 20514905 [Abstract] [Full Text] [Related]
37. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment. Zhou YJ, Wang QW, Zhang QW, Chen JN, Wang XY, Gao YJ, Li XB. Front Endocrinol (Lausanne); 2021 Apr 11; 12():658392. PubMed ID: 34122337 [Abstract] [Full Text] [Related]
38. Morphological, molecular, and prognostic aspects of gastric endocrine tumors. Solcia E, Rindi G, Larosa S, Capella C. Microsc Res Tech; 2000 Mar 15; 48(6):339-48. PubMed ID: 10738315 [Abstract] [Full Text] [Related]
39. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3. Panzuto F, Ramage J, Pritchard DM, van Velthuysen MF, Schrader J, Begum N, Sundin A, Falconi M, O'Toole D. J Neuroendocrinol; 2023 Aug 15; 35(8):e13306. PubMed ID: 37401795 [Abstract] [Full Text] [Related]
40. Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study. Campana D, Ravizza D, Ferolla P, Faggiano A, Grimaldi F, Albertelli M, Berretti D, Castellani D, Cacciari G, Fazio N, Colao A, Ferone D, Tomassetti P. Endocrine; 2016 Jan 15; 51(1):131-9. PubMed ID: 25814125 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]